| 6XQT | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | NNA | enzyme |
| ||||||||||||
| Primary reference | Malleability of the SARS-CoV-2 3CL M(pro) Active-Site Cavity Facilitates Binding of Clinical Antivirals., Kneller DW, Galanie S, Phillips G, O'Neill HM, Coates L, Kovalevsky A, Structure. 2020 Oct 23. pii: S0969-2126(20)30379-8. doi:, 10.1016/j.str.2020.10.007. PMID:33152262 | ||||||||||||||
| Data retrieval |
![]() |
| View 6XQT in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |